The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EONS 2019 | Side effect management in liver and kidney cancer
Bruno Daniele, MD, G. Rummo Hospital, Benevento, Italy, discusses the importance of side effect management in cancer, particularly those from commonly used classes of drugs. He also discusses adverse event management in liver and kidney cancer specifically. This interview took place at EONS 12 during the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
